Development of an MF patient reported outcome (PRO) tool for FDA qualification: Comprehensive literature search and physician cognitive debriefing results
Holly L. Geyer(Mayo Clinic Hospital), Rosa María Alonso Mesa, Jean‐Jacques Kiladjian(Délégation Paris 5), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Alex M. Reiter, Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), Heike L. Pahl(University Medical Center Freiburg), Robyn M. Scherber(Blueprint Medicines (United States)), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), P. Zhang, Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Norman Maldonado(University of Puerto Rico System), Heidi Kosiorek(Mayo Clinic in Florida), Michel D. Ferrari(Leiden University), A. C. Dueck, Konstanze Doehner(University Hospital Ulm), Hubert J. A. Schouten(Maastricht University), F. Boyer, M. Grieshammer, Conrad Harrison(University of Oxford), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Jessica Samuelsson(Karolinska Institutet), Peter A.W. te Boekhorst(Erasmus MC), A. Fuentes, Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gracia Etienne, Tiziano Barbui(University of Bergamo), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Peter Johansson(Linköping University), Julie Cahn, Sonja Zweegman(Vrije Universiteit Amsterdam), K. Bonatz(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Giovanni Barosi(Policlinico San Matteo Fondazione), Zhijun Xu, Jian Xu(Shanghai Pulmonary Hospital), X. Sun, Zhenya Senyak, F. Cervantes(Hospital Clínic de Barcelona), Leyna Roy
Unknown
January 1, 2016
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Depression and cardiovascular disease: a clinical review
|European Heart Journal|2013|1.4k